[
    [
        {
            "time": "2023-10-05",
            "original_text": "Tesla Stock Jumped 20%. It Makes No Sense.",
            "features": {
                "keywords": [
                    "Tesla",
                    "Stock",
                    "Jumped",
                    "20%"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "automotive",
                    "technology"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Tesla Stock Jumped 20%. It Makes No Sense.",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 10,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-05",
            "original_text": "Danaher gets conditional S.Korean regulatory nod for $21 bln GE biopharma unit deal",
            "features": {
                "keywords": [
                    "Danaher",
                    "conditional",
                    "S.Korean",
                    "regulatory",
                    "nod",
                    "GE",
                    "biopharma",
                    "unit",
                    "deal"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotechnology"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Danaher gets conditional S.Korean regulatory nod for $21 bln GE biopharma unit deal",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]